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Abstract
Background: The ingestion of grapes or raisins has been reported to cause acute kid-
ney injury (AKI) in dogs, with a clinical picture dominated by early gastrointestinal
signs and rapidly developing uremia. Ataxia is mentioned in a few reports, but not
further characterized.
Objectives: To evaluate the clinical, laboratory, and pathological features of dogs
diagnosed with grape or raisin toxicosis (GRT) with emphasis on renal and neurologi-
cal manifestations, compared to a control group of dogs with AKI from other causes.
Animals: Fifteen client-owned dogs with GRT and 74 control dogs.
Methods: Retrospective study over 17 months.
Results: All dogs with GRT were presented with severe AKI (grade 4, n = 5; grade 5,
n = 10). Eleven dogs (73%) had marked forebrain, cerebellar, or vestibular signs. These
manifestations dominated the clinical picture in some dogs, but were not associated
with the severity of azotemia or the presence of systemic hypertension. Eight dogs
(53%) survived, and 5 dogs experienced a complete neurological recovery. Causes of
death were unrelated to the neurological manifestations. Neuropathological examina-
tion of 4 dogs did not identify any structural central nervous system abnormality. Only
2 control dogs (3%) displayed neurological signs with seizures unrelated to the AKI;
42 control dogs (57%) survived.
Conclusions and Clinical Importance: Severe forebrain, cerebellar, or vestibular signs
may be an important feature of GRT and dominate the early clinical picture. The
described features suggest a reversible functional brain injury specific to GRT and
unrelated to uremia.
K E YWORD S
acute kidney injury, ataxia, central nervous system, hemodialysis
1 | INTRODUCTION
Several reports of dogs developing acute kidney injury (AKI) after
ingestion of grapes, raisins, or currants have been published since
Abbreviations: AKI, acute kidney injury; BP, systemic blood pressure; GRT, grape or raisin
toxicosis.
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1998.1-8 The mechanism of toxicity is still unknown. Hypotheses
include contamination of fruits with mycotoxins, heavy metals or pes-
ticides, excess vitamin D,1 tannin intolerance or excessive ingestion of
monosaccharides,9 hypovolemic shock, and renal ischemia.4 The exact
amount of ingested fruits necessary to cause damage is unknown, and
estimations are based on clinical cases.4,5,10 The lowest reported dos-
age to cause AKI is 19.6 g/kg body weight for grapes, and 2.8 g/kg for
raisins.5
Reported clinical signs typically include vomiting within 24 (81%
of dogs) to 48 (100% of dogs) hours of ingestion, with vomitus or diar-
rhea fluid possibly containing grapes or swollen raisins.5 Other signs
were compatible with acute uremia and included anorexia, lethargy,
diarrhea, and abdominal pain, as well as oliguria or anuria in 49% of
dogs.1,5 Azotemia developed rapidly within 2 days of ingestion.4 Less
frequent signs reported include dehydration, edema, ptyalism, poly-
uria, polydipsia, hypothermia, hypertension, trembling, seizures, and
ataxia in 23% of dogs. Median onset of ataxia was 2 (range, 0.6-6)
days after ingestion of grapes or raisins. It was associated with a nega-
tive outcome, and in the only survivor affected, clinical signs of ataxia
persisted for 6 days.5 A case report from Korea describes a Yorkshire
Terrier with ataxia that began on the day after grape ingestion. How-
ever, the dog died on day 3, and detailed descriptions of neurological
signs and associated neuropathology are lacking.8
In contrast to previous reports, we observed severe neurological
signs in the dogs presented to the Small Animal Clinic of the Vetsuisse
Faculty Bern, Switzerland, for AKI after grape or raisin toxicosis (GRT),
sometimes dominating the clinical picture and confusing the diagnostic
evaluation. Our retrospective study had the following aims: First, to eval-
uate the clinical, laboratory, pathological, and outcome features of dogs
diagnosed with GRT compared to dogs diagnosed with AKI of other ori-
gin, with emphasis on renal and neurological manifestations; and second,
to investigate potential factors for development of neurological signs by
comparing dogs with and without central nervous system deficits.
2 | MATERIALS AND METHODS
2.1 | Dogs and diagnoses
All dogs diagnosed with AKI at the Small Animal Clinic of the Vetsuisse
Faculty University of Bern between November 2009 and March 2011
were considered for inclusion. The diagnosis of AKI was based on his-
torical, clinical, laboratory, and imaging results, with ≥2 of the following
criteria: (1) presence of renal azotemia with serum creatinine concentra-
tion ≥1.7 mg/dL persisting at least 24 hours after correction of prerenal
factors; (2) increase in serum creatinine concentration ≥0.3 mg/dL dur-
ing a 48 hours period in the absence of prerenal factors; (3) persistent
pathological oligo-anuria (<1 mL/kg/h over 6 hours) after volume reple-
tion; and (4) evidence of tubular injury based on renal glucosuria or
granular casts on urinalysis.11,12 Acute kidney injury was graded at ini-
tial presentation based on the International Renal Interest Society AKI
grading system (http://www.iris-kidney.com, last accessed May
10, 2020).
Dogs with AKI were divided into 2 groups, the dogs with AKI
associated with GRT (group GRT) and control dogs with AKI associ-
ated with other causes (group C). Group GRT included dogs with a his-
tory of witnessed ingestion of grapes or raisins and acute onset of
vomiting within 48 hours after ingestion. Dogs were excluded if inges-
tion of grapes or raisins was suspected but not proven. Group C
included dogs in which the possibility of an ingestion of grapes or rai-
sins could be definitively ruled out and dogs positively diagnosed with
AKI of other causes.
TABLE 1 Signalment and diagnosis
of the 89 dogs included in the study (15
dogs with grape toxicity, grape or raisin
toxicosis [GRT]; 74 control dogs with
acute kidney injury [AKI] of other
etiology, C)
Group GRT (n = 15) Group C (n = 74)
Bonferroni-corrected
P-value
Gender
Male intact 1 (7%) 27 (36%) .03* (male versus female)
Male neutered 3 (20%) 21 (28%)
Female intact 2 (13%) 1 (1%) .93 (intact versus neutered)
Female spayed 9 (60%) 25 (34%)
Purebred dogs 13 (87%) 65 (88%) 1.00
# different breeds 11 41
Age (y) 3.9 (1.3-5.6) 6.6 (2.3-8.8) .26
Body weight (kg) 16.7 (9.9-27.0) 20.1 (11.6-32.1) 1.00
Diagnosis
Leptospirosis 54 (73%)
Toxic nephrosisa 2 (3%)
Polysystemic diseaseb 4 (5%)
Unknown 14 (19%)
aToxic nephrosis: gentamicin, NSAID.
bPolysystemic disease: acute pancreatitis, snake envenomation, Babesia canis infection, postsurgery.
*Statistically significant (P < .05).
2 SCHWEIGHAUSER ET AL.
Data of all dogs were collected retrospectively from medical
records. Data collected included the expanded history including the
time point of grape or raisin ingestion if applicable, physical examination
at least once daily, neurological evaluation twice daily during hospitali-
zation in dogs with neurological signs, and measurement of systemic
blood pressure (BP) by oscillometric technique (Cardell Veterinary
monitor 9403, Midmark Animal Health) according to the American Col-
lege of Veterinary Internal Medicine (ACVIM) guidelines at least once
daily.13 For the purpose of our study, hypertension was defined as a
systolic BP ≥160 mm Hg, which is equivalent to the categories hyper-
tension and severe hypertension with moderate to severe risk of target
organ damage based on the most recent ACVIM guidelines.14
TABLE 2 Relevant clinical and laboratory variables at presentation for the 89 dogs included in the study (15 dogs with grape toxicosis, GRT;
74 control dogs with AKI of other etiology, C)
N = (GRT/C) Group GRT (n = 15) Group C (n = 74) RR
Bonferroni-corrected
P-value
Systolic blood pressure (mm Hg) 144 (129-174) 170 (150-192) 100-140 .05*
Normotension 6/15 (40%) 10/72 (14%)
Prehypertension 3/15 (20%) 13/72 (18%)
Hypertension 4/15 (27%) 21/72 (29%)
Severe hypertension 2/15 (13%) 28/72 (39%)
Laboratory
Hematocrit (L/L) 11/72 0.40 (0.34-0.42) 0.31 (0.27-0.37) 0.39-0.57 .22
WBC (109/L) 11/72 13.2 (8.7-14.7) 15.7 (12.5-22.6) 6.0-12.0 1.00
Platelets (109/L) 10/72 196 (119-236) 158 (83-222) 150-400 1.00
PT (s) 13/69 7.8 (7.2-8.2) 7.9 (7.3-8.7) 6.3-8.5 1.00
aPTT (s) 13/69 12.3 (11.2-13.2) 13.7 (12.1-16.3) 9.6-16.1 .20
Fibrinogen (mg/L) 13/68 196 (167-409) 398 (211-581) 150-300 .50
Creatinine (mg/dL) 15/74 12 (9.2-16.1) 9.1 (5.8-11.9) 0.6-1.4 .52
Urea (mg/dL) 15/74 172 (112-184) 162 (108-207) 10-31 1.00
Ca total (mg/dL) 15/74 13.2 (10.7-14.9) 10.2 (9.3-11.2) 10-11.8 .002*
Ca ionized (mmol/L) 11/36 1.3 (1.1-1.3) 1.1 (1.0-1.2) 1.0-1.4 1.00
Phos (mg/dL) 15/74 12.2 (9.3-18.9) 13 (8.6-17.7) 2.9-6 1.00
Ca × Phos (mmol2/L2) 15/74 12.3 (9.7-20.1) 10.3 (7.5-15.6) <4.7 1.00
Na+ (mEq/L) 15/74 140 (139-141) 141 (137-144) 144-155 1.00
K+ (mEq/L) 15/74 6.2 (5.6-8.5) 4.6 (3.6-6.3) 4.1-5.3 .01*
Glucose (mg/dL) 11/71 110 (90-119) 108 (94-117) 72-117 1.00
Bilirubin (mg/dL) 11/70 0.31 (0.27-0.34) 0.32 (0.2-0.9) 0.04-0.25 1.00
pH 11/36 7.25 (7.24-7.32) 7.30 (7.25-7.33) 7.33-7.51 1.00
HCO3
− (mEq/L) 9/36 16.1 (14.7-18.6) 16.5 (14.1-18.5) 18.4-26.3 1.00
pCO2 (mm Hg) 10/36 37.3 (34-39) 34 (31.1-38.5) 25.2-45.4 1.00
AG (mEq/L) 11/36 25.6 (23.1-33.8) 28.4 (22.8-32.2) 10.8-19.3 1.00
IRIS AKI grading
Grade 2 0 2 (3%)
Grade 3 0 13 (18%)
Grade 4 5 (33%) 30 (41%)
Grade 5 10 (67%) 29 (39%)
RRT 12 (80%) 46 (62%) .48
Oligoanuria 15 (100%) 46/72 (64%) .05
Notes: Blood pressure was classified based on the IRIS recommendations: systolic blood pressure <140 mm Hg, normotension; 140-159 mm Hg,
prehypertension, 160-179 mm Hg, hypertension; ≥180 mm Hg, severe hypertension. The grade of AKI at presentation was defined based on the IRIS recom-
mendations: serum creatinine <140 μmol/L, grade 1; 140-219 μmol/L, grade 2; 220-439 μmol/L, grade 3; 440-879 μmol/L, grade 4; ≥880 μmol/L, grade 5.
Abbreviations: AG, anion gap; AKI, acute kidney injury; aPTT, activated partial thromboplastin time; GRT, grape or raisin toxicosis; IRIS, International Renal
Interest Society; PT, prothrombin time; RR, reference range; RRT, renal replacement treatment; WBC, white blood cell count.
*Statistically significant (P < .05).
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Laboratory results (CBC, serum biochemistry profile, serum ionized
calcium concentration, urinalysis from samples obtained by
cystocentesis) and diagnostic imaging findings (abdominal ultrasound
examination) typically were available from the day of admission and
when clinically indicated thereafter. In anuric dogs, urinalysis usually
was performed as soon as urine production resumed. Bacteriological
culture results of urine were evaluated if available. Serologic testing
for leptospirosis was performed by the National Reference Labora-
tory for Leptospirosis (Institute of Veterinary Bacteriology, National
Center for Zoonoses, Bacterial Animal Diseases and Antimicrobial
Resistance, Vetsuisse Faculty, University of Bern, Bern, Switzerland)
using the microscopic agglutination test (MAT) conducted with a panel
of 11 serovars, Leptospira interrogans serovars Australis, Autumnalis,
Bataviae, Bratislava, Canicola, Hardjo, Icterohemorrhagiae, Pomona,
Sejroe, and Tarassovi, and Leptospira kirschneri serovar Grippotyphosa.
The MAT serology was considered diagnostic of leptospirosis in the
event of seroconversion with a 4-fold increase in paired samples taken
2 weeks apart, or with a single MAT titer ≥1:800.15 In 1 dog, an
expanded toxicological screening (Forensic Toxicology, University of
Bern, Switzerland) of serum and urine was performed using high pres-
sure liquid chromatography tandem mass spectrometry, gas chromatog-
raphy screenings and multi-target screening with liquid chromatography
mass spectrometry.16
2.2 | Treatment and outcome
Medical and dialytic treatments were recorded, considering potential
association with the progression of neurological signs observed in
dogs with GRT. Outcome was defined as discharge from the hospital
and 6-month survival. For nonsurvivors, the main cause of death was
defined as renal, neurological, or other. For survivors, the follow-up of
renal and neurological recovery was recorded as available. Necropsy
and neuro-histopathology of dogs with GRT was performed upon
owner consent.
2.3 | Statistical analyses
Data analyses were performed using commercial software (NCSS
9 Statistical Software, 2013; NCSS, LLC. Kaysville, Utah). A P value
of .05 was used as cutoff for statistical significance after Bonferroni
correction for multiple comparisons.
Descriptive statistics were performed for signalment, laboratory
data, and clinical data. Continuous variables were tested for normal-
ity using a Shapiro-Wilk test. Because multiple variables were not
normally distributed, descriptive statistics were reported as median
and interquartile range. Categorical variables were reported as abso-
lute numbers and proportions. Clinical and laboratory variables were
compared between groups (GRT and C) to evaluate potential charac-
teristics specific for GRT. Clinical and laboratory variables were com-
pared between dogs with and without neurological signs to identify
possible associations with the neurological manifestations.
Continuous variables were compared using a Mann-Whitney U test
and categorical variables using a Chi-square or Fisher's exact test.
Because of potential changes associated with dialysis (eg, osmolal-
ity, blood pressure), specific details of the dialytic treatments are pres-
ented descriptively and separately for the first, second, third, or later
treatments. Urea kinetic modeling was performed using Solute Solver
Lite online software (http://www.ureakinetics.org) to provide the frac-
tional clearances of urea Kt/V with single-pool and equilibrated
models.17 The 2 variables reflecting the interdialytic nitrogen and
protein metabolism, G (urea generation rate), and nPCR (normal-
ized protein catabolic rate) were calculated using a previously
described method for non–steady-state conditions and irregular
schedules.18
F IGURE 1 Comparison of the laboratory variables characterizing
the calcium phosphorus disturbances among 15 dogs with acute
kidney injury (AKI) from grape or raisin toxicosis (GRT) and 74 control
dogs with AKI from other causes (C)
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3 | RESULTS
3.1 | Dogs and diseases
Eighty-nine dogs with AKI met the inclusion criteria during the study
time. Fifteen dogs (17%) were diagnosed with AKI associated with
GRT and 74 dogs (83%) with AKI of other origin. The signalment of
the dogs is summarized in Table 1.
All dogs in group GRT had a known history of ingestion of grapes
or raisins within 72 hours before presentation. Material ingested
included raisins in 2 dogs, grape marc (skins, seeds, and stems of grapes
used for wine production) utilized as a natural fertilizer for grassland in
3 dogs, grapes from compost in 1 dog, and fresh grapes in the other
9 dogs. The exact amount of fruit ingested could not be determined. In
group C, a diagnosis was made in 60/74 dogs (81%, Table 1). In the
remaining 14 dogs (19%), the etiology of AKI was unknown, but expo-
sure to grapes or raisins was considered impossible by the owners.
Physical examination at presentation and during hospitalization of
group GRT identified lethargy (15/15), vomiting (15/15), diarrhea
(8/15), hematochezia (3/15), oligoanuria (15/15), and hypothermia
(15/15). Eleven dogs (73%) in group GRT had marked neurological
signs at presentation. Therefore, neurological examination by a board-
certified neurologist was performed in 8 dogs. The remaining dogs
were examined by board-certified internists and results discussed
with the neurologists.
3.2 | Neurological manifestations
The neurological examination at presentation identified mildly (n = 2)
to severely (n = 5) impaired consciousness, kyphotic posture (n = 1),
pleurothotonus (n = 1), head tilt (n = 1), generalized tremor (n = 2),
generalized ataxia (n = 9, in 1 dog only intermittent), mild ambulatory
tetraparesis (n = 1), drifting (n = 3), and hypermetric gait (n = 2). Pos-
tural reactions were normal in all but 1 dog. Cranial nerve examination
identified bilaterally decreased menace response (n = 2), anisocoria
(n = 1), positional ventral strabismus (n = 2), and decreased nasal sen-
sation (n = 1). One dog had mildly decreased segmental spinal reflexes.
Additionally, 1 dog had a seizure during hospitalization. None of the
dogs had evident pain.
Based on these findings, the neuroanatomical localization of the
lesion was considered multifocal intracranial: forebrain (possibly
TABLE 3 Relevant clinical and laboratory for the 15 dogs diagnosed with AKI because of grape or raisin toxicosis (GRT), stratified upon the
presence of neurological manifestations. Blood pressure was recorded on the day of presentation based on 3 to 5 consecutive measurements
N = neuro/non-neuro GRT with neurological signs (n = 11) GRT without neurological signs (n = 4) RR
Systolic blood pressure (mm Hg) 158 (133-174) 130 (122-174) 100-140
Normotension 3/11 (27%) 3/4 (75%)
Prehypertension 3/11 (27%) 0/4 (0%)
Hypertension 4/11 (36%) 0/4 (0%)
Severe hypertension 1/11 (9%) 1/4 (25%)
Laboratory
Hematocrit (L/L) 9/2 0.39 (0.34-0.43) 0.41 (0.40-0.42) 0.39-0.57
WBC (109/L) 9/2 11.9 (8.5-19) (14.7-14.7) 6.0-12.0
Platelets (109/L) 8/2 205 (134-257) 151 (107-195) 150-400
Creatinine (mg/dL) 11/4 12 (7.2-12.8) 13.5 (9.3-19.1) 0.6-1.4
Urea (mg/dL) 11/4 172 (112-186) 165 (114-180) 10-31
Ca total (mg/dL) 11/4 13.2 (10.7-15.3) 12.6 (10.4-13.8) 10-11.7
Ca ionized (mmol/L) 11/2 1.2 (1-1.3) (1.3-1.3) 1.1-1.4
Phos (mg/dL) 11/4 11.4 (9.3-19.8) 14.2 (9.7-16.4) 2.9-6
Ca × Phos (mmol2/L2) 11/4 12.3 (9.5-21.2) 12.7 (9.8-17.3) <4.7
Na+ (mEq/L) 11/4 140 (138-142) 140 (139-141) 144-155
K+ (mEq/L) 11/4 6.2 (5.8-8.5) 5.7 (4.7-8) 4.1-5.3
Glucose (mg/dL) 9/2 110 (90-119) 86 (81-90) 72-117
Bilirubin (mg/dL) 9/2 0.3 (0.3-0.4) 0.3 (0.3-0.3) 0.04-0.2
pH 10/1 7.28 (7.25-7.33) (7.09) 7.33-7.51
HCO3
− (mEq/L) 8/1 16.5 (14.6-18.7) (15.1) 18.4-26.3
pCO2 (mm Hg) 9/1 36.8 (33.7-37.8) (50.6) 25.2-45.4
AG (mEq/L) 10/1 26.1 (23.1-34.0) (25.1) 10.8-19.3
Abbreviations: AG, anion gap; AKI, acute kidney injury; RR, reference range; WBC, white blood cell count.
SCHWEIGHAUSER ET AL. 5
thalamus) with or without cerebellum in 10 dogs, and peripheral ves-
tibular system in 1 dog.
Neurological signs worsened initially in 6/11 dogs, and regressed
over 2 to 20 days. For most dogs, neurological improvement was mark-
edly slower than improvement of renal function. Six of 11 dogs (55%)
with neurological signs survived and experienced complete neurological
recovery. Five dogs (45%) were euthanized for non-neurological rea-
sons within 1 to 4 days after presentation, at a time where they still
were experiencing neurological deficits.
In group C, only 2/74 dogs (3%) had neurological signs, manifested
as seizures. One of these 2 dogs previously had been diagnosed with idio-
pathic epilepsy, and the other was hypoglycemic as a consequence of
acute liver failure, associated with leptospirosis. Mildly impaired con-
sciousness attributed to uremia was observed in some of the other
72 control dogs. However, in contrast to the deficits observed in the dogs
with GRT, their lethargy resolved rapidly with improvement of azotemia.
3.3 | Blood pressure, laboratory, and imaging
evaluation
Systemic BP at presentation and the proportion of hypertensive dogs
was significantly lower in dogs with GRT than in controls (P = .05
and .04, respectively; Table 2). Five of the 6 hypertensive dogs with
GRT had neurological abnormalities, which persisted despite successful
BP control after treatment with amlodipine besylate (Amlodipin Mepha,
Mepha Pharma AG, Switzerland) 0.25 to 0.75 mg/kg PO q24h in 4 dogs
and with correction of fluid overload by dialysis in 1 dog.
Relevant laboratory variables and AKI grading for both groups at
presentation are presented in Table 2. In summary, serum potassium
concentration was higher in the GRT group, likely reflecting some-
what more severe renal impairment, with a higher proportion of dogs
with oligoanuria than observed in control dogs. The most distinctive
feature of GRT was the markedly higher serum total calcium concen-
tration with similar serum phosphorus and ionized calcium concentra-
tions, compared to C group (Figure 1). No obvious difference was
observed in laboratory findings between dogs with or without neuro-
logical signs in group GRT (Table 3) and no obvious association was
found between the severity of azotemia and the severity of neurologi-
cal signs.
Toxicological analysis of blood and urine of 1 dog with GRT and
neurological signs identified traces of alcohol, including 0.3 mg/L ethyl
glucuronide and 0.2 mg/L ethyl sulfate, but no other toxic substances.
This sample was taken at presentation, but 4 days after ingestion of
grapes.
Indirect intracranial pressure assessment using transcranial Dopp-
ler sonography was performed in 1 dog with progressive neurological
signs and normal BP.19 The resistive index was 0.80 for the basilar
artery (normal ≤0.66) and 0.89 for the middle cerebral artery (normal
≤0.58), suggesting increased intracranial pressure.
TABLE 4 Main variables describing the 54 hemodialysis treatments in 12 dogs with AKI because of ingestion of grapes or raisins
Tx1 n = 12 Tx2 n = 12 Tx3 n = 11 Tx>3 n = 19
N treatments/dog 4 (3-5)
Dialysis modality
HD 10 (83%) 7 (58%) 6 (55%) 15 (79%)
HDF 2 (17%) 5 (42%) 5 (45%) 4 (21%)
Anticoagulation
SH 6 (50%) 6 (50%) 5 (45%) 13 (68%)
RCA 6 (50%) 6 (50%) 6 (55%) 6 (32%)
Td (min) 111 (90-123) 160 (148-191) 207 (183-220) 210 (180-265)
Qp (L/kg) 372 (309-414) 692 (608-1018) 1272 (1021-1391) 1596 (1374-1769)
Qb (mL/min/kg) 3.3 (3.1-4.1) 4.6 (3.7-6.4) 6.1 (5.1-7.0) 7.4 (5.8-8.5)
ΔBW (%) 0.92 (0.00 to 1.64) 0.85 (−1.30 to 2.70) 0.38 (−1.23 to 1.11) 0.41 (−1.40 to 1.39)
UF (mL/kg) 11.6 (1.5-20.9) 19.1 (0.3-35.0) 30.3 (0.3-47.5) 49.3 (12.5-63.4)
CrRR 0.33 (0.27-0.38) 0.51 (0.44-0.55) 0.65 (0.64-0.68) 0.70 (0.67-0.77)
URR 0.39 (0.33-0.44) 0.57 (0.43-0.64) 0.75 (0.71-0.79) 0.83 (0.80-0.87)
spKt/V 0.50 (0.42-0.61) 0.93 (0.56-1.19) 1.67 (1.53-1.92) 1.99 (1.72-2.26)
eKt/V 0.37 (0.33-0.50) 0.76 (0.47-1.02) 1.43 (1.29-1.63) 1.71 (1.45-2.00)
G (mg/min) 4.19 (2.20-5.28) 2.35 (1.61-3.73) 2.70 (1.85-4.20) 2.40 (1.55-3.21)
nPCR (g/kg/d) 1.86 (1.36-2.82) 1.35 (1.03-1.81) 1.19 (0.98-1.84) 1.04 (0.81-1.25)
Abbreviations: ΔBW, change in body weight; CrRR, creatinine reduction ration; eKt/V, fractional clearance of the urea distribution volume (equilibrated
values); G, urea generation rate; nPCR, normalized protein catabolic rate; Qb, blood flow rate; Qp, volume of blood processed; spKt/V, fractional clearance
of the urea distribution volume (single-pool kinetic model); Td, duration of the dialysis treatment; UF, ultrafiltration volume; URR, urea reduction ratio.
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3.4 | Treatment
Treatment strategy was identical in both groups of dogs. Twelve of
15 dogs (80%) in group GRT were treated by hemodialysis, compared to
46/74 dogs (62%) for group C. Relevant specifics of the dialysis treatment
for dogs with GRT are summarized in Table 4. Medications administered
to dogs of this group included balanced electrolyte solutions, amoxicillin-
clavulanic acid (n = 11), metronidazole (n = 3), enrofloxacin (n = 3), doxy-
cycline (n = 1), ranitidine (n = 11), omeprazole (n = 3), dolasetron (n = 9),
maropitant (n = 6), buprenorphine (n = 9), methadone (n = 2), furosemide
(n = 4), amlodipine (n = 4), salicylate (n = 1), diazepam (n = 1), phenobarbi-
tal (n = 1), dexamethasone (n = 1), 25% glucose (n = 2), darbepoeitin
(n = 1), sodium bicarbonate (n = 1), and mannitol (n = 12).
3.5 | Outcome
Eight dogs (53%) of group GRT survived and were discharged from the
hospital. Of these, 5 had neurological signs during the acute phase of ill-
ness and experienced complete neurological recovery. Seven dogs were
discharged with partial renal recovery (serum creatinine concentration
<3.05 mg/dL) and 1 dog with normal renal function test results. Six of
the 7 nonsurvivors had neurological signs, but died or were euthanized
for renal-related reasons (n = 4) or other non-neurological causes
(n = 3), 2 of them while still dialysis-dependent. Follow-up by phone
was performed for the 8 survivors of group GRT, which all were still
alive 9 to 13 months after discharge from the hospital. In 6 dogs, serum
creatinine and urea concentrations were within normal limits at the last
reevaluations with their referring veterinarians, and in 2 dogs, the
owners had declined further blood reevaluations since discharge with
mildly increased renal function test results (serum creatinine concentra-
tions 2.99 mg/dL and 1.58 mg/dL, respectively).
In comparison, 42/74 dogs (57%) in group C survived and were dis-
charged. Nonsurvivors died or were euthanized for renal-related reasons
(n = 10) or nonrenal related causes (n = 22). None of the dogs was
euthanized because of neurological problems. Seventeen of the 32 non-
survivors were still dialysis-dependent at the time of death or euthanasia.
3.6 | Pathology
Necropsy was performed in 4 dogs with GRT and neurological signs,
and a kidney biopsy sample was obtained from an additional dog with
GRT. The findings indicated acute renal tubular necrosis consistent with
grape toxicosis.6 In 1 dog, histopathological examination showed
multifocal to confluent degeneration and necrosis of tubular epithelium
and concurrent multifocal mild tubular regeneration. Many epithelial
cells contained intracytoplasmic golden brown pigment and numerous
tubular lumina contained eosinophilic granular casts (Figure 2A). One
dog with severely increased calcium × phosphorus product of 28.5
(mmol/L)2 had severe diffuse metastatic calcification of proximal tubules
within the renal cortex, whereas medullary tubules were spared. Severe
diffuse calcification also was noted in the alveolar walls of the lungs and
was associated with hyperemia and multifocal hemorrhages (Figure 2B).
Similar findings of severe mineralization of the proximal tubules were
observed in a second dog with mild to moderate hypercalcemia.
Neurohistopathological examination of the brain and spinal cord
was unremarkable in all 4 dogs examined. None of them had been
hypertensive.
4 | DISCUSSION
Ingestion of grapes or raisins is known to cause AKI in some
dogs.1-7 Based on our findings, neurological signs of variable sever-
ity, when present, are mainly localized to the forebrain (presump-
tively thalamus) and cerebellum and seem to be an important
feature in >75% of the dogs. These neurological manifestations may
even dominate the early clinical picture and confuse the initial diag-
nostic evaluation.
F IGURE 2 Histopathology of the kidney (3A) and lung (3B) of a dog with acute kidney injury (AKI) from grape or raisin toxicosis. A, Kidney:
lumina of tubules contain eosinophilic proteinaceous material admixed with sloughed and necrotic epithelial cells (stars). HE stain, ×400. B, Lung:
alveolar walls are mineralized (arrows), free erythrocytes, and many macrophages can be seen in the alveolar space
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To date, the toxic agent causing renal damage is still unknown, as
is the pathogenesis of the neurological manifestations. Whether the
impairment of both organ systems is caused by the same toxin or
pathophysiology is therefore unclear. Other potential causes for neu-
rological involvement including severe uremia, systemic hypertension,
electrolyte and metabolic derangements, adverse drug effects, and
structural damage to the central nervous system with hemorrhage or
thromboses were investigated in our study.
Uremic encephalopathy is a well-described entity in human medi-
cine, resulting in complex mental changes and motor disturbances,20
whereas similar publications in the veterinary literature are sparse.21,22
The pathophysiology seems to be multifactorial, including accumulation
of protein degradation products, such as guanidine and methylguanidine,
that possibly act as uremic neurotoxins. Other factors include malfunc-
tion of intermediary metabolism, hormonal disturbances, and imbalance
between excitatory and inhibitory neurotransmitters.23-25 In particular,
secondary hyperparathyroidism may contribute to the pathogenesis of
uremic encephalopathy. In humans with renal failure, calcium concentra-
tion in the brain is increased, likely because of altered parathyroid
hormone-sensitive calcium transport within neurons. Increased cellular
calcium may cause neuro-excitation and possibly contribute to clinical
signs of encephalopathy.20
Similar to a previous study, dogs of group GRT showed a statisti-
cally significant increase in serum calcium concentration compared to
control dogs.5 This increase was limited to the total serum calcium
concentration and did not include the ionized fraction. Because serum
albumin concentration was not different from that of the control dogs
(data not shown), this finding suggests accumulation of calcium com-
plexed to unidentified anions not reflected in the anion gap. This
increase of serum calcium concentration in dogs with GRT may have
led to severe calcification of the renal tubules and the alveolar walls
observed on histopathology. Apart from these structural changes,
hypercalcemia may have contributed to functional hemodynamic dis-
turbances in the kidney by vasoconstriction of the afferent arteriole in
the glomeruli, although this effect would rather be expected with ion-
ized hypercalcemia.26
A potential role for hypercalcemia in the neurological manifesta-
tions is difficult to evaluate with the available data. The serum calcium
concentrations were not strikingly different between dogs with or
without neurological signs, and mineralization was not detectable in
the central nervous system of the examined dogs with neurological
signs. However, a nonstructural effect of the hypercalcemia leading to
brain dysfunction cannot be excluded.
Other electrolyte disturbances including potassium, sodium, chloride,
and phosphorus were not significantly different between the groups, and
thus unlikely to be a causative factor for the neurological manifestations.
The neurological signs could be directly caused by a component or
metabolite of grapes and raisins. The trace amount of alcohol found in
1 dog with GRT caused by grape marc ingestion likely developed during
the fermention process but was too low to directly cause the neurologi-
cal signs observed, especially for the duration of several days.
All dogs with GRT developed oligoanuric AKI with severe azotemia.
However, the difference in the severity of renal impairment between the
groups was minimal and none of the control dogs showed neurological
signs attributable to uremia other than mild transient impaired mentation.
Additionally, no structural lesion was observed in the brain compatible
with secondary uremic changes such as myelin vacuolization as described
in a goat.21 It is thus unlikely that the neurological manifestations
observed in these dogs after GRT are caused by uremic encephalopathy.
Dialysis-related neurological signs such as dialysis disequilibrium
were excluded because all but 1 dog showed neurological signs at the
time of presentation before initiation of extracorporeal blood purifica-
tion treatment.23 Similarly, aluminum hydroxide toxicosis can be ruled
out as a contributing factor, because this phosphorus binder was only
administered after the onset of neurological signs and only in a subset
of dogs.27 Other medications administered before referral or during
hospitalization for treatment of AKI were not different between the
2 groups or between dogs with and without neurological manifestation,
which makes direct drug toxicosis or drug interactions very unlikely.
Systemic hypertension is a well-known cause of renal failure in
human and veterinary medicine and it may lead to infarctions or hem-
orrhages in the central nervous system.13 In our study, systemic
hypertension with a moderate to severe risk of target organ damage
was present in 6/15 dogs (40%) of the group GRT. Five of these
6 dogs had neurological signs, and these persisted in all of them
despite successful medical control of their blood pressure. Further-
more, control dogs overall were more hypertensive than dogs with
GRT and without showing neurological signs. Systemic hypertension
therefore seems unlikely to be a causative factor for the neurological
signs of dogs with GRT. In humans with renal failure, hypertensive
encephalopathy occurs in approximately 5% of cases, and is thought
to be caused by vasogenic edema predominantly in the caudal areas
of the brain because of impaired cerebrovascular autoregulation,
increased plasma concentrations of natriuretic peptides and endothe-
lial injury.23 The high resistive index of the cerebral vessels observed
in 1 dog possibly indicates increased intracranial pressure in this dog
and warrants more systematic assessment in the future.
Summarizing the various individual causes for neurological signs,
we cannot exclude that some of them, although not alone responsible
for the neurological disturbances, may have aggravated the primary
cause. Hemodialysis may have the potential to increase the intracra-
nial pressure, and therefore special caution is mandatory while writing
the treatment prescription. Also, analgesics may have a stronger effect
in uremic patients compared to normal dogs, and hence worsen the
lethargy observed.
Overall, the short-term survival rate of 53% in dogs with AKI after
GRT in our study is comparable to that of previous reports and similar to
the survival rate of 57% in the control dogs with other causes of AKI.5
To our knowledge, ours is the first report of long-term outcome in dogs
with GRT with nearly complete renal recovery in survivors >6 months
after discharge. Also, treatment of GRT-induced AKI has not been
reported in a large number of cases so far, including dialysis treatments.
More than 75% of the dogs with GRT showed severe neurological
signs, which were reversible in all dogs that survived. The remaining
dogs were still neurologically abnormal by the time of euthanasia or
death. It therefore is not clear that the neurological manifestations are
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always reversible, but based on the short survival time of the non-
surviving dogs that were still neurologically abnormal, they likely did not
have enough time to regain normal neurological status before death.
The main limitations of our study include a low number of dogs
with GRT and the 2 dogs lost to follow-up for long-term outcome.
However, in our opinion, the severity of neurological signs in the
affected dogs and the intensive staging, monitoring, treatment and
follow-up of all patients with renal disease at our facility, strengthen
the value of our study. Other limitations include the low number of
GRT dogs that underwent neuropathological examination because of
owner constraints, as well as the fact that most control dogs were
diagnosed with leptospirosis (73%), which is a systemic infection with
various organ manifestations in addition to renal function impairment.
However, despite the fact that central nervous system involvement is
described with leptospirosis, only 2 of the control dogs with leptospi-
rosis had neurological signs.28 One dog suffered from hypoglycemia
because of leptospirosis-associated liver failure, and the other dog
was previously diagnosed with idiopathic epilepsy.
In conclusion, neurological signs seem to be an important feature
of GRT in some dogs and they even may dominate the early clinical pic-
ture of this toxicosis before signs of uremia emerge. It thus should be
an important differential diagnosis along with ethylene glycol poisoning
in dogs presenting with severe gastrointestinal and neurological signs.
Importantly, neurological signs seem to be reversible and unrelated to
the severity of uremia, the presence of systemic hypertension, electro-
lyte disorders, or other metabolic derangements. The absence of struc-
tural changes and the reversibility of the signs suggest functional brain
alterations. The pathophysiology of this neurological dysfunction still
could include direct neurotoxicity, consequences of disturbances in cal-
cium metabolism, or increased intracranial pressure, which should be
addressed in future studies.
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